Capricor Therapeutics, Inc.
CAPR
$31.17
$0.270.87%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -22.79% | 5.17% | -6.23% | -242.74% | 43.32% |
| Total Depreciation and Amortization | 1.60% | 1.73% | 19.93% | 7.93% | 4.01% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 65.67% | 20.69% | -38.19% | 145.51% | 17.24% |
| Change in Net Operating Assets | -20,405.26% | -99.66% | -85.68% | 211.79% | -602.36% |
| Cash from Operations | -19.70% | 2.15% | -212.77% | 56.52% | -27.09% |
| Capital Expenditure | -27.82% | -176.57% | -27.13% | -55.21% | -1,145.25% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 141.54% | 24.76% | -36.08% | 120.41% | -6,043.06% |
| Cash from Investing | 170.13% | 9.63% | -39.10% | 119.36% | -6,254.92% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3,554,405.71% | -64.29% | -61.11% | -99.94% | 20.44% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3,554,405.71% | -64.29% | -61.11% | -99.94% | 20.44% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7,292.48% | 32.82% | -131.72% | 130.67% | -198.96% |